Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer (Q83831101)
Jump to navigation
Jump to search
scientific article published on 11 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer |
scientific article published on 11 April 2011 |
Statements
Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer (English)
Howard I Scher
Xiaoyu Jia
Kim Chi
Ronald de Wit
William R Berry
Peter Albers
Brian Henick
David Waterhouse
Dean J Ruether
Peter J Rosen
Anthony A Meluch
Luke T Nordquist
Peter M Venner
Axel Heidenreich
Luis Chu
Glenn Heller
11 April 2011